| Panel | ||||||
|---|---|---|---|---|---|---|
| ||||||
JSON File: ct_service_enrolment.json |
Questions | Concepts |
|---|---|
What do you want to do? 🔘 Enrol a new client 🔘 Transfer in a client 🔘 Enrol a Mother into PMTCT program 🔘 Re-enrol a client | |
Enrolment Date ␣␣-␣␣-␣␣␣␣ 📆 | |
Unique ID __________________________________ | |
Other Unique ID __________________________________ | |
Entry Point 🔽 Voluntary male circumcision clinic 🔽 Private home-based care 🔽 Adolescent outreach program 🔽 Private Company 🔽 Outreach program 🔽 Community-based organization 🔽 Outpatient department 🔽 Pediatric inpatient service 🔽 Voluntary counseling and testing program 🔽 Maternal and child health program 🔽 Vaccination service 🔽 Nutrition program 🔽 Sex worker outreach program 🔽 Intravenous venous drug user outreach program 🔽 Sexually transmitted infection program/clinic 🔽 Under five clinic 🔽 Tuberculosis treatment program 🔽 Adult inpatient service | |
Entry Point - Other __________________________________ | |
Population Category 🔘 General population 🔘 Key population 🔘 Priority population | |
Key Population Type 🔘 Intravenous drug user 🔘 Male who has sex with men 🔘 Prisoners 🔘 Sex worker 🔘 Transgender Persons | |
Priority Population Type 🔽 Adolescent Girls & Young Women 🔽 Client of sex worker 🔽 Fisher Folk 🔽 Long-distance truck driver 🔽 Migrant Workers 🔽 Non-intravenous drug user 🔽 Refugee 🔽 Uniformed Forces 🔽 Other | |
Transfer-In | |
Transferring Facility __________________________________ | |
Start ART Date ␣␣-␣␣-␣␣␣␣ 📆 | |
Regimen 🔽 ABC + 3TC + DTG | 164432 ARV regimen/code for drugs collected
|
Date of Enrolment into HIV Care ␣␣-␣␣-␣␣␣␣ 📆 | |
HIV Diagnosis | |
Date Confirmed HIV Positive ␣␣-␣␣-␣␣␣␣ 📆 | |
Test Type 🔘 Rapid test for HIV 🔘 HIV DNA polymerase chain reaction 🔘 Unknown | |
Previous ARV/HAART Use | |
Indication/intent of therapy ☑️ Pre Exposure Prophylaxis (PrEP) ☑️ Prevention of Mother to Child Transmission (PMTCT) ☑️ Post-exposure prophylaxis (PEP) | |
Use of Pre Exposure Prophylaxis (PrEP) | |
Use of Post-exposure prophylaxis (PEP)***CC | 164845 Eligible for post-exposure prophylaxis Antiretroviral drugs used |
ART Use for Prevention of Mother to Child Transmission of HIV***CC | 163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program |
Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC | NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS) ARVs |
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC | NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs |
Protease Inhibitors (PIS)***CC | ProteaseInhibitorsProtease Inhibitors (PIS) ARVs |
Other HIV Drug Classes | 1085 Antiretroviral 1193 Current drugs |
Treatment Supporter | |
Treatment Supporter Name __________________________________ | |
Treatment Supporter Phone Number __________________________________ | |
Treatment Supporter Relationship 🔽 Sibling 🔽 Parent 🔽 Partner or spouse 🔽 Guardian 🔽 Grandparent 🔽 Other | |
Re-enrollment | |
Date of Re-enrollment ␣␣-␣␣-␣␣␣␣ 📆 | |
Reason For Re-enrolment __________________________________ | |